Your browser doesn't support javascript.
loading
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1.
Alghamri, Mahmoud S; Thalla, Rohit; Avvari, Ruthvik P; Dabaja, Ali; Taher, Ayman; Zhao, Lili; Ulintz, Peter J; Castro, Maria G; Lowenstein, Pedro R.
Afiliación
  • Alghamri MS; Department of Neurosurgery, University of Michigan Medical School, MSRB II, Ann Arbor, Michigan, USA.
  • Thalla R; Department of Cell and Developmental Biology, University of Michigan Medical School, MSRB II, Ann Arbor, Michigan, USA.
  • Avvari RP; Department of Neurosurgery, University of Michigan Medical School, MSRB II, Ann Arbor, Michigan, USA.
  • Dabaja A; Department of Cell and Developmental Biology, University of Michigan Medical School, MSRB II, Ann Arbor, Michigan, USA.
  • Taher A; Department of Neurosurgery, University of Michigan Medical School, MSRB II, Ann Arbor, Michigan, USA.
  • Zhao L; Department of Cell and Developmental Biology, University of Michigan Medical School, MSRB II, Ann Arbor, Michigan, USA.
  • Ulintz PJ; Department of Neurosurgery, University of Michigan Medical School, MSRB II, Ann Arbor, Michigan, USA.
  • Castro MG; Department of Cell and Developmental Biology, University of Michigan Medical School, MSRB II, Ann Arbor, Michigan, USA.
  • Lowenstein PR; Department of Neurosurgery, University of Michigan Medical School, MSRB II, Ann Arbor, Michigan, USA.
Neurooncol Adv ; 2(1): vdaa042, 2020.
Article en En | MEDLINE | ID: mdl-32642696

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neurooncol Adv Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neurooncol Adv Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos